KLEBCIL Drug Patent Profile
✉ Email this page to a colleague
When do Klebcil patents expire, and what generic alternatives are available?
Klebcil is a drug marketed by King Pharms and is included in one NDA.
The generic ingredient in KLEBCIL is kanamycin sulfate. There are five drug master file entries for this compound. Additional details are available on the kanamycin sulfate profile page.
Summary for KLEBCIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 137 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KLEBCIL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for KLEBCIL
US Patents and Regulatory Information for KLEBCIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pharms | KLEBCIL | kanamycin sulfate | INJECTABLE;INJECTION | 062170-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
King Pharms | KLEBCIL | kanamycin sulfate | INJECTABLE;INJECTION | 062170-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
King Pharms | KLEBCIL | kanamycin sulfate | INJECTABLE;INJECTION | 062170-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |